JPWO2020011976A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020011976A5 JPWO2020011976A5 JP2021500386A JP2021500386A JPWO2020011976A5 JP WO2020011976 A5 JPWO2020011976 A5 JP WO2020011976A5 JP 2021500386 A JP2021500386 A JP 2021500386A JP 2021500386 A JP2021500386 A JP 2021500386A JP WO2020011976 A5 JPWO2020011976 A5 JP WO2020011976A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nos
- antibody molecule
- domain
- set forth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023169048A JP2023178323A (ja) | 2018-07-12 | 2023-09-29 | メソテリン及びｃｄ１３７結合分子 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1811450.4 | 2018-07-12 | ||
| GBGB1811450.4A GB201811450D0 (en) | 2018-07-12 | 2018-07-12 | Mesothelin and CD137 binding molecules |
| PCT/EP2019/068817 WO2020011976A1 (en) | 2018-07-12 | 2019-07-12 | Mesothelin and cd137 binding molecules |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023169048A Division JP2023178323A (ja) | 2018-07-12 | 2023-09-29 | メソテリン及びｃｄ１３７結合分子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021524269A JP2021524269A (ja) | 2021-09-13 |
| JPWO2020011976A5 true JPWO2020011976A5 (es) | 2022-07-20 |
| JP7360441B2 JP7360441B2 (ja) | 2023-10-12 |
Family
ID=63273224
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500386A Active JP7360441B2 (ja) | 2018-07-12 | 2019-07-12 | メソテリン及びｃｄ１３７結合分子 |
| JP2023169048A Pending JP2023178323A (ja) | 2018-07-12 | 2023-09-29 | メソテリン及びｃｄ１３７結合分子 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023169048A Pending JP2023178323A (ja) | 2018-07-12 | 2023-09-29 | メソテリン及びｃｄ１３７結合分子 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210309753A1 (es) |
| EP (1) | EP3820894A1 (es) |
| JP (2) | JP7360441B2 (es) |
| KR (1) | KR20210030925A (es) |
| CN (1) | CN112437776B (es) |
| AR (1) | AR115769A1 (es) |
| AU (1) | AU2019303081A1 (es) |
| BR (1) | BR112021000396A2 (es) |
| CA (1) | CA3103173A1 (es) |
| GB (1) | GB201811450D0 (es) |
| IL (1) | IL280007A (es) |
| MX (1) | MX2021000397A (es) |
| SG (1) | SG11202011960XA (es) |
| TW (1) | TWI839365B (es) |
| WO (1) | WO2020011976A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201612520D0 (en) | 2016-07-19 | 2016-08-31 | F-Star Beta Ltd | Binding molecules |
| WO2019121906A1 (en) | 2017-12-19 | 2019-06-27 | F-Star Beta Limited | Specific pd-l1 binding sequences inserted in a ch3 domain |
| MA52366A (fr) | 2018-04-25 | 2021-03-03 | Prometheus Biosciences Inc | Anticorps anti-tl1a optimisés |
| GB201811408D0 (en) | 2018-07-12 | 2018-08-29 | F Star Beta Ltd | CD137 Binding Molecules |
| WO2020081895A2 (en) * | 2018-10-18 | 2020-04-23 | The Scripps Research Institute | Siv envelope trimer |
| AU2020371725A1 (en) | 2019-10-24 | 2022-05-26 | Cedars-Sinai Medical Center | Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof |
| WO2024039672A2 (en) * | 2022-08-15 | 2024-02-22 | Dana-Farber Cancer Institute, Inc. | Antibodies against msln and methods of use thereof |
| WO2024042105A1 (en) | 2022-08-26 | 2024-02-29 | Merck Patent Gmbh | Cancer treatment comprising an anti-msln/cd137 antibody and a chemotherapeutic |
| WO2024042104A1 (en) | 2022-08-26 | 2024-02-29 | Merck Patent Gmbh | Combination cancer treatment comprising an anti-msln/cd137 antibody and pd-1/pd-l1 inhibitor |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| WO2000073346A1 (en) | 1999-05-27 | 2000-12-07 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Immunoconjugates having high binding affinity |
| US7288638B2 (en) | 2003-10-10 | 2007-10-30 | Bristol-Myers Squibb Company | Fully human antibodies against human 4-1BB |
| EA018897B1 (ru) | 2005-01-05 | 2013-11-29 | Ф-Стар Биотехнологише Форшунгс- Унд Энтвиклунгсгез.М.Б.Х. | Молекулы иммуноглобулина, содержащие модифицированные участки структурных петель, обладающие свойством связывания, и способ их получения |
| KR101559599B1 (ko) | 2007-11-26 | 2015-10-12 | 바이엘 인텔렉쳐 프로퍼티 게엠베하 | 항-메소텔린 항체 및 이의 용도 |
| EP2113255A1 (en) | 2008-05-02 | 2009-11-04 | f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. | Cytotoxic immunoglobulin |
| EP2900695B1 (en) * | 2012-09-27 | 2018-01-17 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Mesothelin antibodies and methods for eliciting potent antitumor activity |
| KR101782487B1 (ko) * | 2015-09-24 | 2017-09-27 | 재단법인 목암생명과학연구소 | 신규 항-메소텔린 항체 및 이를 포함하는 조성물 |
| EP3445788B1 (en) * | 2016-04-22 | 2022-01-19 | Alligator Bioscience AB | Novel bispecific polypeptides against cd137 |
| TW201806972A (zh) * | 2016-05-27 | 2018-03-01 | 美商艾伯維生物醫療股份有限公司 | 雙特異性結合蛋白 |
| CN107523546A (zh) * | 2016-06-20 | 2017-12-29 | 上海细胞治疗研究院 | 一种高效稳定表达抗体的nk细胞及其用途 |
-
2018
- 2018-07-12 GB GBGB1811450.4A patent/GB201811450D0/en not_active Ceased
-
2019
- 2019-07-12 TW TW108124775A patent/TWI839365B/zh active
- 2019-07-12 WO PCT/EP2019/068817 patent/WO2020011976A1/en active Application Filing
- 2019-07-12 JP JP2021500386A patent/JP7360441B2/ja active Active
- 2019-07-12 EP EP19742323.9A patent/EP3820894A1/en active Pending
- 2019-07-12 AR ARP190101973A patent/AR115769A1/es unknown
- 2019-07-12 AU AU2019303081A patent/AU2019303081A1/en active Pending
- 2019-07-12 BR BR112021000396-7A patent/BR112021000396A2/pt unknown
- 2019-07-12 US US17/259,634 patent/US20210309753A1/en active Pending
- 2019-07-12 MX MX2021000397A patent/MX2021000397A/es unknown
- 2019-07-12 CA CA3103173A patent/CA3103173A1/en active Pending
- 2019-07-12 KR KR1020217000265A patent/KR20210030925A/ko unknown
- 2019-07-12 SG SG11202011960XA patent/SG11202011960XA/en unknown
- 2019-07-12 CN CN201980046873.7A patent/CN112437776B/zh active Active
-
2021
- 2021-01-07 IL IL280007A patent/IL280007A/en unknown
-
2023
- 2023-09-29 JP JP2023169048A patent/JP2023178323A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023178323A5 (es) | ||
| JPWO2019129221A5 (es) | ||
| JP2019526273A5 (es) | ||
| RU2015144098A (ru) | Четырехвалентные биспецифические антитела | |
| JP5738294B2 (ja) | 抗ｖｅｇｆモノクローナル抗体およびその抗体を含む薬学的組成物 | |
| CN110799539A (zh) | 抗4-1bb抗体及其制备和使用方法 | |
| JP2017522891A5 (es) | ||
| JP2019511201A5 (es) | ||
| CA2487060A1 (en) | Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency | |
| JP2021159081A5 (es) | ||
| JP2013500703A5 (es) | ||
| JP2008532559A5 (es) | ||
| JP2007532139A5 (es) | ||
| JPWO2019147831A5 (es) | ||
| JP2022009816A5 (es) | ||
| JPWO2020011976A5 (es) | ||
| JP2008507253A5 (es) | ||
| JPWO2020011964A5 (es) | ||
| JPWO2020011968A5 (es) | ||
| JPWO2020011970A5 (es) | ||
| JPWO2020011966A5 (es) | ||
| JPWO2020011974A5 (es) | ||
| JP2019518473A5 (es) | ||
| IL312060A (en) | Bispecific CD16A binders | |
| JPWO2020011972A5 (es) |